Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients
Abstract
Abstract Background: Susceptibility MRI may capture Parkinson's disease‐related pathology. This study delineated longitudinal changes in different substantia nigra regions. Methods: Seventy‐two PD patients and 62 controls were studied at both baseline and after 18 months with MRI. R2* and quantitative susceptibility mapping values from the substantia nigra pars compacta and substantia nigra pars reticulata were calculated. Mixed‐effects models compared controls with PD or PD subgroups having different disease durations: early (<1 year), middle (<5 years, middle‐stage PD), and late (>5 years, late‐stage PD). Pearson's correlation assessed associations between imaging and clinical measures. Results: At baseline, R2* and quantitative susceptibility mapping were higher in both the substantia nigra pars compacta and substantia nigra pars reticulata in all PD patients (group effect, P ≤ 0.003). Longitudinally, the substantia nigra pars compacta R2* showed a faster increase in PD compared with controls (time × group, P = 0.002), whereas quantitative susceptibility mapping did not ( P = 0.668). The substantia nigra pars reticulata R2* and quantitative susceptibility mapping did not differ between PD and controls (time × group, P ≥ 0.084), although both decreased longitudinally (time effect, P ≤ 0.004). Baseline substantia nigra pars compacta R2* was higher in all PD subgroups (group, P ≤ 0.006), but showed a significantly faster increase onlymore »
- Authors:
-
- Department of Neurology Penn State University‐Milton S. Hershey Medical Center Hershey Pennsylvania United States
- Department of Neurology Penn State University‐Milton S. Hershey Medical Center Hershey Pennsylvania United States, Department of Pharmacology Penn State University‐Milton S. Hershey Medical Center Hershey Pennsylvania United States
- Department of Radiology Penn State University‐Milton S. Hershey Medical Center Hershey Pennsylvania United States
- School of Public Health Shanxi Medical University Taiyuan Shanxi China
- Department of Neurosurgery Penn State University‐Milton S. Hershey Medical Center Hershey Pennsylvania United States
- Department of Public Health Sciences Penn State University‐Milton S. Hershey Medical Center Hershey Pennsylvania United States
- Department of Neurology Penn State University‐Milton S. Hershey Medical Center Hershey Pennsylvania United States, Department of Pharmacology Penn State University‐Milton S. Hershey Medical Center Hershey Pennsylvania United States, Department of Radiology Penn State University‐Milton S. Hershey Medical Center Hershey Pennsylvania United States, Department of Neurosurgery Penn State University‐Milton S. Hershey Medical Center Hershey Pennsylvania United States, Department of Kinesiology Penn State University‐Milton S. Hershey Medical Center Hershey Pennsylvania United States
- Publication Date:
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1437062
- Resource Type:
- Publisher's Accepted Manuscript
- Journal Name:
- Movement Disorders
- Additional Journal Information:
- Journal Name: Movement Disorders Journal Volume: 33 Journal Issue: 9; Journal ID: ISSN 0885-3185
- Publisher:
- Wiley Blackwell (John Wiley & Sons)
- Country of Publication:
- Country unknown/Code not available
- Language:
- English
Citation Formats
Du, Guangwei, Lewis, Mechelle M., Sica, Christopher, He, Lu, Connor, James R., Kong, Lan, Mailman, Richard B., and Huang, Xuemei. Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients. Country unknown/Code not available: N. p., 2018.
Web. doi:10.1002/mds.27318.
Du, Guangwei, Lewis, Mechelle M., Sica, Christopher, He, Lu, Connor, James R., Kong, Lan, Mailman, Richard B., & Huang, Xuemei. Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients. Country unknown/Code not available. https://doi.org/10.1002/mds.27318
Du, Guangwei, Lewis, Mechelle M., Sica, Christopher, He, Lu, Connor, James R., Kong, Lan, Mailman, Richard B., and Huang, Xuemei. Mon .
"Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients". Country unknown/Code not available. https://doi.org/10.1002/mds.27318.
@article{osti_1437062,
title = {Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients},
author = {Du, Guangwei and Lewis, Mechelle M. and Sica, Christopher and He, Lu and Connor, James R. and Kong, Lan and Mailman, Richard B. and Huang, Xuemei},
abstractNote = {Abstract Background: Susceptibility MRI may capture Parkinson's disease‐related pathology. This study delineated longitudinal changes in different substantia nigra regions. Methods: Seventy‐two PD patients and 62 controls were studied at both baseline and after 18 months with MRI. R2* and quantitative susceptibility mapping values from the substantia nigra pars compacta and substantia nigra pars reticulata were calculated. Mixed‐effects models compared controls with PD or PD subgroups having different disease durations: early (<1 year), middle (<5 years, middle‐stage PD), and late (>5 years, late‐stage PD). Pearson's correlation assessed associations between imaging and clinical measures. Results: At baseline, R2* and quantitative susceptibility mapping were higher in both the substantia nigra pars compacta and substantia nigra pars reticulata in all PD patients (group effect, P ≤ 0.003). Longitudinally, the substantia nigra pars compacta R2* showed a faster increase in PD compared with controls (time × group, P = 0.002), whereas quantitative susceptibility mapping did not ( P = 0.668). The substantia nigra pars reticulata R2* and quantitative susceptibility mapping did not differ between PD and controls (time × group, P ≥ 0.084), although both decreased longitudinally (time effect, P ≤ 0.004). Baseline substantia nigra pars compacta R2* was higher in all PD subgroups (group, P ≤ 0.006), but showed a significantly faster increase only in later‐stage PD (time × group, P < 0.0001) that correlated with changes in nonmotor symptoms ( r = 0.746, P = 0.002). Baseline substantia nigra pars reticulata quantitative susceptibility mapping was higher in middle‐stage PD and later‐stage PD (group, P ≤ 0.002), but showed a longitudinal decrease (time × group, P = 0.004) only in later‐stage PD that correlated with changes in motor signs ( r = 0.837, P < 0.001). Conclusion: Susceptibility MRI revealed distinct patterns of PD progression in the substantia nigra pars compacta and substantia nigra pars reticulata. The different patterns are particularly clear in later‐stage patients. These findings may resolve past controversies and have implications in the pathophysiological processes during PD progression. © 2018 International Parkinson and Movement Disorder Society},
doi = {10.1002/mds.27318},
journal = {Movement Disorders},
number = 9,
volume = 33,
place = {Country unknown/Code not available},
year = {Mon May 14 00:00:00 EDT 2018},
month = {Mon May 14 00:00:00 EDT 2018}
}
https://doi.org/10.1002/mds.27318
Web of Science
Works referenced in this record:
Progression marker of Parkinson’s disease: a 4-year multi-site imaging study
journal, July 2017
- Burciu, Roxana G.; Ofori, Edward; Archer, Derek B.
- Brain, Vol. 140, Issue 8
Imaging Brain Iron and Diffusion Patterns
journal, January 2014
- Rossi, Maija Elina; Ruottinen, Hanna; Saunamäki, Tiia
- Academic Radiology, Vol. 21, Issue 1
Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson’s Disease Stages?
journal, April 2016
- Hopes, Lucie; Grolez, Guillaume; Moreau, Caroline
- PLOS ONE, Vol. 11, Issue 4
Ageing and Parkinson'S Disease: Substantia Nigra Regional Selectivity
journal, January 1991
- Fearnley, Julian M.; Lees, Andrew J.
- Brain, Vol. 114, Issue 5
Magnetic resonance imaging as a potential biomarker for Parkinson's disease
journal, September 2016
- Tuite, Paul
- Translational Research, Vol. 175
The pattern of gray matter atrophy in Parkinson’s disease differs in cortical and subcortical regions
journal, October 2015
- Lewis, Mechelle M.; Du, Guangwei; Lee, Eun-Young
- Journal of Neurology, Vol. 263, Issue 1
Magnetic resonance imaging markers of Parkinson’s disease nigrostriatal signature
journal, August 2010
- Péran, Patrice; Cherubini, Andrea; Assogna, Francesca
- Brain, Vol. 133, Issue 11
Rate of progression in Parkinson's disease: A 6-[18F]fluoro-L-dopa PET study
journal, January 2001
- Nurmi, Elina; Ruottinen, Hanna M.; Bergman, J�rgen
- Movement Disorders, Vol. 16, Issue 4
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
journal, October 1988
- Sofic, E.; Riederer, P.; Heinsen, H.
- Journal of Neural Transmission, Vol. 74, Issue 3
Iron in parkinsonian and control substantia nigra?A m�ssbauer spectroscopy study
journal, January 1996
- Ga???zka-Friedman, J.; Bauminger, E. R.; Friedman, A.
- Movement Disorders, Vol. 11, Issue 1
Iron and Aluminum Increase in the Substantia Nigra of Patients with Parkinson's Disease: An X-Ray Microanalysis
journal, February 1991
- Hirsch, E. C.; Brandel, J. -P.; Galle, P.
- Journal of Neurochemistry, Vol. 56, Issue 2
A reproducible evaluation of ANTs similarity metric performance in brain image registration
journal, February 2011
- Avants, Brian B.; Tustison, Nicholas J.; Song, Gang
- NeuroImage, Vol. 54, Issue 3
Contributions to magnetic susceptibility of brain tissue: Magnetic Susceptibility of Brain Tissue
journal, May 2016
- Duyn, Jeff H.; Schenck, John
- NMR in Biomedicine, Vol. 30, Issue 4
Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease
journal, July 2014
- Devos, David; Moreau, Caroline; Devedjian, Jean Christophe
- Antioxidants & Redox Signaling, Vol. 21, Issue 2
Is R2* a New MRI Biomarker for the Progression of Parkinson’s Disease? A Longitudinal Follow-Up
journal, March 2013
- Ulla, Miguel; Bonny, Jean Marie; Ouchchane, Lemlih
- PLoS ONE, Vol. 8, Issue 3
[99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease
journal, May 2005
- Siderowf, A.; Newberg, A.; Chou, K. L.
- Neurology, Vol. 64, Issue 10
Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease
journal, June 1989
- Dexter, D. T.; Wells, F. R.; Lee, A. J.
- Journal of Neurochemistry, Vol. 52, Issue 6
The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward: MRI in Parkinsonian Disorders
journal, March 2017
- Lehericy, Stéphane; Vaillancourt, David E.; Seppi, Klaus
- Movement Disorders, Vol. 32, Issue 4
Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study
journal, November 2010
- Iranzo, Alex; Lomeña, Francisco; Stockner, Heike
- The Lancet Neurology, Vol. 9, Issue 11
Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
journal, July 2013
- Kordower, Jeffrey H.; Olanow, C. Warren; Dodiya, Hemraj B.
- Brain, Vol. 136, Issue 8
Imaging iron stores in the brain using magnetic resonance imaging
journal, January 2005
- Haacke, E. Mark; Cheng, Norman Y. C.; House, Michael J.
- Magnetic Resonance Imaging, Vol. 23, Issue 1
Neuroimaging biomarkers for Parkinson disease: Facts and fantasy: Neuroimaging Biomarkers for PD
journal, November 2014
- Perlmutter, Joel S.; Norris, Scott A.
- Annals of Neurology, Vol. 76, Issue 6
Longitudinal changes in free-water within the substantia nigra of Parkinson’s disease
journal, May 2015
- Ofori, Edward; Pasternak, Ofer; Planetta, Peggy J.
- Brain, Vol. 138, Issue 8
Unified Parkinson’s Disease Rating Scale-Motor Exam: inter-rater reliability of advanced practice nurse and neurologist assessments: Neurological assessment inter-rater reliability
journal, April 2010
- Palmer, Janice L.; Coats, Mary A.; Roe, Catherine M.
- Journal of Advanced Nursing, Vol. 66, Issue 6
Susceptibility MRI captures nigral pathology in patients with parkinsonian syndromes: R2* and QSM Reflect Pathology in Parkinsonism
journal, May 2018
- Lewis, Mechelle M.; Du, Guangwei; Baccon, Jennifer
- Movement Disorders, Vol. 33, Issue 9
Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker: QSM
journal, July 2014
- Wang, Yi; Liu, Tian
- Magnetic Resonance in Medicine, Vol. 73, Issue 1
Imaging nigral pathology and clinical progression in Parkinson's disease
journal, September 2012
- Du, Guangwei; Lewis, Mechelle M.; Sen, Suman
- Movement Disorders, Vol. 27, Issue 13
Cognitive Impairments in Early Parkinson's Disease Are Accompanied by Reductions in Activity in Frontostriatal Neural Circuitry
journal, July 2003
- Lewis, Simon J. G.; Dove, Anja; Robbins, Trevor W.
- The Journal of Neuroscience, Vol. 23, Issue 15
Caffeine Intake, Smoking, and Risk of Parkinson Disease in Men and Women
journal, April 2012
- Liu, R.; Guo, X.; Park, Y.
- American Journal of Epidemiology, Vol. 175, Issue 11
Ceruloplasmin activity and iron chelation treatment of patients with Parkinson’s disease
journal, May 2015
- Grolez, Guillaume; Moreau, Caroline; Sablonnière, Bernard
- BMC Neurology, Vol. 15, Issue 1
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
journal, March 1992
- Hughes, A. J.; Daniel, S. E.; Kilford, L.
- Journal of Neurology, Neurosurgery & Psychiatry, Vol. 55, Issue 3
Susceptibility phase imaging with comparison to R2* mapping of iron-rich deep grey matter
journal, July 2011
- Walsh, Andrew J.; Wilman, Alan H.
- NeuroImage, Vol. 57, Issue 2, p. 452-461
Midbrain iron content in early Parkinson disease: A potential biomarker of disease status
journal, January 2008
- Martin, W. R. W.; Wieler, M.; Gee, M.
- Neurology, Vol. 70, Issue Issue 16, Part 2
Longitudinal midbrain changes in early Parkinson's disease: Iron content estimated from R2*/MRI
journal, March 2015
- Wieler, Marguerite; Gee, Myrlene; Martin, W. R. Wayne
- Parkinsonism & Related Disorders, Vol. 21, Issue 3
Substantia Nigra Pars Reticulata Neurons in Parkinson's Disease
journal, March 1996
- Hardman, C. D.; McRitchie, D. A.; Halliday, G. M.
- Neurodegeneration, Vol. 5, Issue 1
Quantitative susceptibility mapping of the midbrain in Parkinson's disease: Nigral Iron in PD
journal, September 2015
- Du, Guangwei; Liu, Tian; Lewis, Mechelle M.
- Movement Disorders, Vol. 31, Issue 3
Stability of R2* and quantitative susceptibility mapping of the brain tissue in a large scale multi-center study
journal, March 2017
- Wang, Rongpin; Xie, Guangyou; Zhai, Maoxiong
- Scientific Reports, Vol. 7, Issue 1
Parkinson's disease beyond 20 years
journal, October 2014
- Cilia, Roberto; Cereda, Emanuele; Klersy, Catherine
- Journal of Neurology, Neurosurgery & Psychiatry, Vol. 86, Issue 8
The Relevance of Iron in the Pathogenesis of Parkinson's Disease
journal, March 2004
- GÖTz, Mario E.; Double, Kay; Gerlach, Manfred
- Annals of the New York Academy of Sciences, Vol. 1012, Issue 1